Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Diabetes

Free Subscription 26.01.2026 2 Am J Clin Nutr 2 Am J Hypertens 1 Am J Kidney Dis 1 Am J Ophthalmol 2 Ann Intern Med 2 Biochem Biophys Res Commun 2 Circ Heart Fail 6 Diabet Med 5 Diabetes 13 Diabetes Care 21 Diabetes Obes Metab 8 Diabetologia 1 Hypertension 1 Invest Ophthalmol Vis Sci 1 J Am Coll Cardiol 6 J Am Soc Nephrol 5 J Clin Endocrinol Metab 2 J Nutr 3 JAMA 1 Ophthalmology 2 Pediatr Diabetes 6 PLoS One 1 Transplantation

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Nutr

1. WANG B, Luo K, Ma W, Zhang Y, et al
   Metabolome contribution to sex differences in the link between alcohol consumption and type 2 diabetes: a prospective analysis in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
   Am J Clin Nutr. 2026 Jan 21:101203. doi: 10.1016/j.ajcnut.2026.101203.
   PubMed         Abstract available
   
   
2. LI SX, Imamura F, Sharp SJ, Schulze MB, et al
   Interactions between genetic predisposition to obesity, insulin resistance and type 2 diabetes risk and food or beverage intake for incident type 2 diabetes: European Prospective Investigation into Cancer (EPIC) InterAct case-cohort study.
   Am J Clin Nutr. 2026 Jan 16:101198. doi: 10.1016/j.ajcnut.2026.101198.
   PubMed         Abstract available
   
   

   
   Am J Hypertens

3. ZHANG Y, Lin Z, He X, Lu J, et al
   Childhood Obesity Raises GDM Risk Through Adult Obesity: Evidence From Lifecourse Mendelian Randomization Study.
   Am J Hypertens. 2026;39:143-151.
   PubMed         Abstract available
   
   
4. MOLLER CA, Nielsen SF, Mose FH
   The Effect of SGLT2 Inhibitors on Blood Pressure in Relation to Baseline Kidney Function: A Systematic Literature Review and Data Analysis.
   Am J Hypertens. 2026;39:122-133.
   PubMed         Abstract available
   
   

   
   Am J Kidney Dis

5. YAU K, Ray JG, Jeyakumar N, Luo B, et al
   Glucagon-like Peptide-1 Receptor Agonists and Risk of Major Adverse Cardiovascular Events in Patients With CKD.
   Am J Kidney Dis. 2026;87:211-229.
   PubMed         Abstract available
   
   

   
   Am J Ophthalmol

6. HE L, Guo X, Yong Z, Zha Y, et al
   Reply to Comment on: Choroidal-Derived Intraretinal Neovascularization Compensates for Diabetic Retinopathy Ischemia via Dual-Pathway Remodeling Post-PRP.
   Am J Ophthalmol. 2026 Jan 20:S0002-9394(26)00022.
   PubMed        
   
   

   
   Ann Intern Med

7. PATTI ME, Hu B, Kirschling S, Wang HJ, et al
   Effect of Social Vulnerability on Efficacy of Bariatric Surgery Versus Medical and Lifestyle Intervention for Type 2 Diabetes: Analysis of the ARMMS-T2D Consortium of Randomized Trials.
   Ann Intern Med. 2026 Jan 20. doi: 10.7326/ANNALS-24-01882.
   PubMed         Abstract available
   
   
8. HEERSPINK HJL, Grams ME, Sang Y, Ballew SH, et al
   Proteinuria or Albuminuria as Markers of Kidney and Cardiovascular Disease Risk : An Individual Patient-Level Meta-analysis.
   Ann Intern Med. 2025 Nov 4. doi: 10.7326/ANNALS-25-02117.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

9. UEMURA T, Tomita K, Eriguchi M, Torisu K, et al
   High expression of angiotensin-converting enzyme in macrophages exacerbates renal interstitial damage in diabetic mice.
   Biochem Biophys Res Commun. 2026;801:153308.
   PubMed         Abstract available
   
   
10. ZHANG W, Zhang K, Xu W, Sun X, et al
    Microbiota-targeted modulation of the gut-kidney axis in diabetic kidney disease: Therapeutic advances and future perspectives.
    Biochem Biophys Res Commun. 2026;800:153294.
    PubMed         Abstract available
    
    

    
    Circ Heart Fail

11. ODUTAYO A, Bhatt DL, Sridhar VS, Szarek M, et al
    Association Between the 2022 AHA/ACC/HFSA Heart Failure Staging and Cardiovascular and Kidney Outcomes in Patients With Diabetes and Kidney Disease: A Post Hoc Analysis of the SCORED Randomized Controlled Trial.
    Circ Heart Fail. 2026 Jan 22:e013054. doi: 10.1161/CIRCHEARTFAILURE.125.013054.
    PubMed         Abstract available
    
    
12. ECHOUFFO-TCHEUGUI JB, Ndumele CE, Chen J, Rooney MR, et al
    Proteomic Signatures of Cardiac Dysfunction Among People With Diabetes: The Atherosclerosis Risk in Communities Study.
    Circ Heart Fail. 2026 Jan 22:e013171. doi: 10.1161/CIRCHEARTFAILURE.125.013171.
    PubMed         Abstract available
    
    

    
    Diabet Med

13. ROBERTS CM, Carreon SA, Minard CG, Lyons SK, et al
    Lean on me: Social factors and diabetes outcomes among young adults with type 1 diabetes prior to transitioning to adult care.
    Diabet Med. 2026 Jan 18:e70205. doi: 10.1111/dme.70205.
    PubMed         Abstract available
    
    
14. KIM S, Park S, Jin SM, Kim JH, et al
    Association of perceived diabetes stigma with time below range <3.0 mmol/L and anxiety in adults with type 1 diabetes using continuous glucose monitoring.
    Diabet Med. 2026 Jan 18:e70204. doi: 10.1111/dme.70204.
    PubMed         Abstract available
    
    
15. LI GF, Tian G
    Methodological and reporting appraisal of a nationwide cohort study on socio-economic deprivation and survival in diabetes post-myocardial infarction.
    Diabet Med. 2026 Jan 18:e70229. doi: 10.1111/dme.70229.
    PubMed        
    
    
16. STIMSON RH, Dover AR, Lyall MJ, Barclay JI, et al
    Ketone test strip use is low in adults with type 1 diabetes and is not associated with HbA1c or glucose metrics on continuous glucose monitoring.
    Diabet Med. 2026 Jan 18:e70228. doi: 10.1111/dme.70228.
    PubMed        
    
    
17. STRAKOSCH T, Forbes S
    A UK key opinion leader perspective: Navigating the immunological and logistical transformation brought by stem cell-derived islets for the treatment of type 1 diabetes.
    Diabet Med. 2026 Jan 20:e70230. doi: 10.1111/dme.70230.
    PubMed         Abstract available
    
    
18. MURFET G, Carey N, Ng AH, Walters R, et al
    Digital technologies and clinical decision support tools available for diabetes triage in the inpatient setting: A systematic literature review.
    Diabet Med. 2026 Jan 22:e70233. doi: 10.1111/dme.70233.
    PubMed         Abstract available
    
    

    
    Diabetes

19. GREENBAUM CJ, Long SA, Gitelman SE, Gaglia JL, et al
    Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes.
    Diabetes. 2026 Jan 21:db250777. doi: 10.2337/db25-0777.
    PubMed         Abstract available
    
    
20. LIU C, Lee IXY, Xue CC, Yu M, et al
    Diabetic Corneal Neuropathy Precedes and Is Associated With Diabetic Retinopathy.
    Diabetes. 2026 Jan 21:db250590. doi: 10.2337/db25-0590.
    PubMed         Abstract available
    
    
21. SCHON M, Oehler D, Yurchenko I, Lang A, et al
    Integrating SMRT and Bulk RNA Sequencing With Metabolic Phenotyping to Examine Reduced Skeletal Muscle Mitochondrial Respiration in Type 2 Diabetes.
    Diabetes. 2026 Jan 21:db250625. doi: 10.2337/db25-0625.
    PubMed         Abstract available
    
    
22. LIN MC, Chen SC
    Urinary Dickkopf-3 Reveals Tubular Fibrosis and Hidden Progression in Diabetic Kidney Disease.
    Diabetes. 2026;75:e1-e2.
    PubMed        
    
    
23. DONG L, Lin S, Slavin J, Gunnam S, et al
    Phosphatidylserine Supplementation Improves Metabolic Liver Disease and Glycemic Control in the Presence of Suppressed Oxidative Glucose Metabolism.
    Diabetes. 2026;75:273-287.
    PubMed         Abstract available
    
    

    
    Diabetes Care

24. WAGNER R, Selvin E, Sehgal R, Prystupa K, et al
    Beyond Glucose-Rethinking Prediabetes for Precision Prevention.
    Diabetes Care. 2026;49:226-235.
    PubMed         Abstract available
    
    
25. GE J, Han S, Shi M, Harada M, et al
    Integrative Metabolomics of Targeted and Nontargeted Analyses in T2D Progression.
    Diabetes Care. 2026;49:282-291.
    PubMed         Abstract available
    
    
26. KHINE A, Sanda S, Torok C, Quandt Z, et al
    Glucocorticoids to Manage Cytokine Release Syndrome During Teplizumab Therapy for New-Onset Type 1 Diabetes.
    Diabetes Care. 2026 Jan 20:dc252494. doi: 10.2337/dc25-2494.
    PubMed        
    
    
27. GONZALEZ JS, Wen H, Butera NM, Uschner D, et al
    Medication Adherence in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
    Diabetes Care. 2026;49:335-343.
    PubMed         Abstract available
    
    
28. KAHN SE, Anderson CAM, Buse JB, Selvin E, et al
    "Community Voices": Something New in Diabetes Care.
    Diabetes Care. 2026;49:214.
    PubMed        
    
    
29. MAKAREM N, Yuan Y, Al-Rousan T, Ghosh AK, et al
    Response to Comment on Yuan et al. Associations of Concurrent Hypertension and Type 2 Diabetes With Mortality Outcomes: A Prospective Study of U.S. Adults. Diabetes Care 48:1241-1250.
    Diabetes Care. 2026;49:e31-e32.
    PubMed        
    
    
30. XIONG J, Xu W
    Comment on Yuan et al. Associations of Concurrent Hypertension and Type 2 Diabetes With Mortality Outcomes: A Prospective Study of U.S. Adults: Diabetes Care 2025;48:1241-1250.
    Diabetes Care. 2026;49:e30.
    PubMed        
    
    
31. LOPEZ JKM
    Diabetes, A Health Disparity.
    Diabetes Care. 2026;49:215.
    PubMed        
    
    
32. PAGE B
    About the Editor: Kristen Nadeau, MD, MS-Improving Prediction Measures for Early-Onset Type 2 Diabetes.
    Diabetes Care. 2026;49:225.
    PubMed        
    
    
33. HEGGIE V
    New Perspectives: Four Unsung Heroes of Diabetes Research.
    Diabetes Care. 2026;49:216-222.
    PubMed         Abstract available
    
    
34. BILAL A, Osorio S, Casu A
    Severe Hypoglycemia in Insulin-Treated Type 2 Diabetes: A Call to Revisit Diabetes Education.
    Diabetes Care. 2026;49:236-238.
    PubMed        
    
    
35. HUGHES RCE, Abraham E, Chan H, Williman JA, et al
    Rapid Postpartum Progression to Diabetes Following Early Antenatal Prediabetes: Evidence From a Multiethnic New Zealand Cohort.
    Diabetes Care. 2026 Jan 21:dc252200. doi: 10.2337/dc25-2200.
    PubMed         Abstract available
    
    
36. ZIEGLER AG, Albeer A, Arnolds S, Assfalg R, et al
    Effect of High-Dose Oral Insulin in Children With Stage 1 Type 1 Diabetes: The Fr1da Insulin Intervention Randomized Controlled Trial.
    Diabetes Care. 2026 Jan 21:dc252818. doi: 10.2337/dc25-2818.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

37. PINDER L, Rickwood S, Konrad M, Kostev K, et al
    Annual prevalence of the body mass index documentation in the UK primary care: A cross-sectional study using IQVIA medical research data.
    Diabetes Obes Metab. 2026;28:1482-1489.
    PubMed         Abstract available
    
    
38. BOURRON O, Denimal D
    Efficacy and safety of once-weekly insulins in type 2 diabetes: A systematic review and meta-analysis.
    Diabetes Obes Metab. 2026 Jan 23. doi: 10.1111/dom.70497.
    PubMed         Abstract available
    
    
39. AZEGAMI T, Kaneko H, Okada A, Suzuki Y, et al
    SGLT2 inhibitors and mortality in older adults with diabetic kidney disease: A target trial emulation study.
    Diabetes Obes Metab. 2026 Jan 23. doi: 10.1111/dom.70502.
    PubMed         Abstract available
    
    
40. MARTENS T, Battelino T, Heller S, Bhargava A, et al
    CGM-derived efficacy and overall safety of once-weekly insulin efsitora alfa (efsitora) relative to day of administration in adults with type 2 diabetes.
    Diabetes Obes Metab. 2026 Jan 22. doi: 10.1111/dom.70419.
    PubMed        
    
    
41. LIU X, Liang Z, Liu C, Ma Y, et al
    Oral indole-3-propionic acid preserves beta-cell function and improves glucose homeostasis in diabetic mice via FOXA1-SGPP1-HSPA5 signalling.
    Diabetes Obes Metab. 2026 Jan 21. doi: 10.1111/dom.70471.
    PubMed         Abstract available
    
    
42. TAKAHASHI Y, Hayashi M, Kato T, Horikawa Y, et al
    BALLAST study: A multicentre, open-label, randomized-controlled, 52-week clinical trial of the efficacy and safety of luseogliflozin in older Japanese adults with type 2 diabetes receiving leucine-enriched amino acid supplementation and physical exerc
    Diabetes Obes Metab. 2026 Jan 21. doi: 10.1111/dom.70494.
    PubMed        
    
    
43. ZHANG Z, Zhao L, Wang Z, Zhou X, et al
    Lipoprotein(a) is associated with ASCVD in individuals with non-diabetes, prediabetes, or diabetes independent of CRP.
    Diabetes Obes Metab. 2026 Jan 21. doi: 10.1111/dom.70491.
    PubMed         Abstract available
    
    
44. MONNIER L, Owens D
    New paths to attenuate the burden of hypoglycaemia in type 1 diabetes.
    Diabetes Obes Metab. 2026 Jan 21. doi: 10.1111/dom.70512.
    PubMed        
    
    
45. WANG Y, Meng X, Zhang X, Li M, et al
    Longitudinal exposure to non-HDL-C and cardiovascular events, all-cause mortality in type 2 diabetes: A post hoc analysis of the ACCORD trial.
    Diabetes Obes Metab. 2026 Jan 21. doi: 10.1111/dom.70498.
    PubMed         Abstract available
    
    
46. CROOS J, Shooshtarian AK, Stotesbury B, Gallen G, et al
    Clinical outcomes of adults with type 1 diabetes and comorbid depression and/or anxiety disorders using hybrid closed-loop: A retrospective study from a multidisciplinary tertiary centre.
    Diabetes Obes Metab. 2026 Jan 20. doi: 10.1111/dom.70432.
    PubMed         Abstract available
    
    
47. PSCHERER S, Fritsche A, Anderten H, Pegelow K, et al
    Efficacy and safety of switching basal insulin to insulin glargine 300 U/mL in individuals with inadequately controlled type 2 diabetes on advanced insulin therapies: The Toujeo-Neo T2DM study.
    Diabetes Obes Metab. 2026 Jan 20. doi: 10.1111/dom.70417.
    PubMed         Abstract available
    
    
48. CHEVALIER C, Rodrigues Oliveira A, Wargny M, Cloteau C, et al
    Methylglyoxal-glycated apolipoproteins A-I and A-II are associated with new-onset diabetes in individuals with prediabetes.
    Diabetes Obes Metab. 2026 Jan 20. doi: 10.1111/dom.70493.
    PubMed        
    
    
49. GARRE TI, Guedet CG, Alexandre-Heymann L, Messier V, et al
    Association between daily steps, diabetes management and health indicators in people living with type 1 diabetes: A cross-sectional study from the BETTER registry.
    Diabetes Obes Metab. 2026 Jan 20. doi: 10.1111/dom.70473.
    PubMed         Abstract available
    
    
50. TATEWAKI T, Okada A, Kimura Y, Yasunaga H, et al
    Risk of acute pancreatitis with DPP-4 inhibitors versus SGLT2 inhibitors in medication-naive individuals with diabetes: A target trial emulation.
    Diabetes Obes Metab. 2026 Jan 20. doi: 10.1111/dom.70490.
    PubMed         Abstract available
    
    
51. TIAN X, Wu S, Xia X, Xu Q, et al
    Cardiovascular outcomes under hypothetical blood-pressure-lowering intervention in type 2 diabetes: A target trial emulation.
    Diabetes Obes Metab. 2026 Jan 20. doi: 10.1111/dom.70472.
    PubMed         Abstract available
    
    
52. VERMA A, Upadhyay A
    Diabetic kidney disease, biomarkers, and finerenone.
    Diabetes Obes Metab. 2026 Jan 19. doi: 10.1111/dom.70464.
    PubMed         Abstract available
    
    
53. JONES AM, Hallworth P, Kendal H, Mottershead C, et al
    Preferences for basal insulin treatments in adults with type 2 diabetes: A discrete choice experiment in France and Spain.
    Diabetes Obes Metab. 2026 Jan 19. doi: 10.1111/dom.70422.
    PubMed         Abstract available
    
    
54. AKMAL M, Tariq S, Mustafa M, Gulzar G, et al
    Efficacy of once-weekly insulin efsitora versus once-daily basal insulin in type 2 diabetes: A systematic review and meta-analysis.
    Diabetes Obes Metab. 2026 Jan 19. doi: 10.1111/dom.70399.
    PubMed         Abstract available
    
    
55. GUTIERREZ DE PINERES V, Tamayo-Torres CS, Ramirez-Cisneros A, Kavelidou M, et al
    Effects of liraglutide treatment for 18 days on metabolic parameters, regional body composition and the myostatin-activin-follistatin-IGF-1 axis: Results from an exploratory, randomized, placebo-controlled, crossover study.
    Diabetes Obes Metab. 2026;28:1258-1265.
    PubMed         Abstract available
    
    
56. ZHAO M, Liu Y, Huang W, Song G, et al
    Long-term glycemic exposure, glycemic control stability and incident calcific aortic valve disease: A prospective cohort study.
    Diabetes Obes Metab. 2026;28:1081-1089.
    PubMed         Abstract available
    
    
57. ALFONSO ARVEZ MJ, Tan GSQ, Ademi Z, Ilomaki J, et al
    Initiation of sodium-glucose cotransporter-2 inhibitors and the risk of infection-related hospitalisations: A population-based cohort study.
    Diabetes Obes Metab. 2026;28:1057-1067.
    PubMed         Abstract available
    
    

    
    Diabetologia

58. TSAMERET S, Froy O, Matz Y, Landau Z, et al
    Glycaemic, appetite and circadian benefits of a dairy-enriched diet with high-protein breakfast and early daytime-restricted carbohydrate intake in type 2 diabetes: a randomised crossover trial.
    Diabetologia. 2026 Jan 23. doi: 10.1007/s00125-025-06658.
    PubMed         Abstract available
    
    
59. MALLONE R, Bandini A
    Type 1 diabetes screening: building a clinician-patient partnership for early care of chronic beta cell failure.
    Diabetologia. 2026 Jan 23. doi: 10.1007/s00125-025-06656.
    PubMed        
    
    
60. SCARAMUZZA AE, Iafusco D, Cherubini V
    Type 1 diabetes screening: reframing the debate from paternalism to partnership.
    Diabetologia. 2026 Jan 23. doi: 10.1007/s00125-025-06654.
    PubMed        
    
    
61. LEHMANN G, Ehrmann D, Olesen B, Priesterroth LS, et al
    Uncovering distinct predictors of diabetes distress and depressive symptoms in a longitudinal survival analysis of incidence and remission: indication for diverging aetiological paths.
    Diabetologia. 2026 Jan 22. doi: 10.1007/s00125-026-06666.
    PubMed         Abstract available
    
    
62. SYREENI A, Dahlstrom EH, Smyth LJ, Hill C, et al
    Blood DNA methylation markers are associated with diabetic kidney disease progression in type 1 diabetes.
    Diabetologia. 2026 Jan 22. doi: 10.1007/s00125-025-06661.
    PubMed         Abstract available
    
    
63. TOKGOZ S, Deden LN, Hofboer A, Meijer RI, et al
    Beta cell function and mass in individuals with and without remission of type 2 diabetes after Roux-en-Y gastric bypass.
    Diabetologia. 2026 Jan 20. doi: 10.1007/s00125-025-06659.
    PubMed         Abstract available
    
    
64. LAL R, Braune K, Lewis DM, Petruzelkova L, et al
    Fully closed-loop systems: can people with type 1 diabetes just do it? Insights from open-source systems.
    Diabetologia. 2026 Jan 19. doi: 10.1007/s00125-025-06644.
    PubMed         Abstract available
    
    
65. OZ OK, Sherwood AM, Crisologo PA, Killeen AL, et al
    Prospective comparison of WBC SPECT/CT and conventional MRI for diagnosing osteomyelitis and monitoring treatment response in diabetic foot infections.
    Diabetologia. 2026 Jan 18. doi: 10.1007/s00125-025-06652.
    PubMed         Abstract available
    
    

    
    Hypertension

66. IWAKURA T, Kidokoro K, Tatsugawa R, Hirano A, et al
    Finerenone Improves Albuminuria via MR-TRPC Signaling in Diabetic Kidney Disease.
    Hypertension. 2026 Jan 22. doi: 10.1161/HYPERTENSIONAHA.125.25739.
    PubMed         Abstract available
    
    

    
    Invest Ophthalmol Vis Sci

67. LV K, Peng J, Wang H, Li Y, et al
    Olink Proteomic Profiling of Vitreous Humor and Plasma From Proliferative Diabetic Retinopathy Patients Identifies a Novel Inflammatory Molecular Endotype.
    Invest Ophthalmol Vis Sci. 2026;67:47.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

68. WANG S, Wang K, Gu H, Zhang J, et al
    Blood Pressure Levels and Outcomes in Type 2 Diabetes: Dose-Response Meta-Analysis of 5.87 Million Cohort Participants.
    J Am Coll Cardiol. 2026 Jan 14:S0735-1097(25)10148.
    PubMed         Abstract available
    
    

    
    J Am Soc Nephrol

69. LEVIN-IAINA N, Reiner-Benaim A, Abu-Akel S, Habashi N, et al
    Clinical Implications of Missed CKD Diagnosis in Adults with and without Diabetes Mellitus.
    J Am Soc Nephrol. 2026 Jan 14. doi: 10.1681/ASN.0000001005.
    PubMed         Abstract available
    
    
70. CHEUNG CY, Lee CH, Lam KS, Xu A, et al
    Authors' Reply: Proteomic CKD Prediction in Type 2 Diabetes: Underexplored Limitations and Translational Gaps.
    J Am Soc Nephrol. 2026 Jan 6. doi: 10.1681/ASN.0000000992.
    PubMed        
    
    
71. BALZER MS, Zhou J, Abedini A, Ma Z, et al
    Single-Cell Resolution Drug Effects of Renin-Angiotensin-Aldosterone Blockade in ZSF1 Rat Diabetic Kidney Disease.
    J Am Soc Nephrol. 2026 Jan 7. doi: 10.1681/ASN.0000000995.
    PubMed         Abstract available
    
    
72. CHEN SC, Lee YT
    Proteomic CKD Prediction in Type 2 Diabetes: Underexplored Limitations and Translational Gaps.
    J Am Soc Nephrol. 2026 Jan 6. doi: 10.1681/ASN.0000000991.
    PubMed        
    
    
73. HOFHERR A, Maki-Petaja K, Selvarajah V, Grice D, et al
    Inhibition of IL-33 in Diabetic Kidney Disease: A Randomized, Placebo-Controlled Phase 2b Trial.
    J Am Soc Nephrol. 2025 Dec 5. doi: 10.1681/ASN.0000000966.
    PubMed        
    
    
74. XU C, Cheung CY, Zhong J, Lin Y, et al
    A Five-Plasma Protein-Based Algorithm for Predicting Incident CKD in Type 2 Diabetes.
    J Am Soc Nephrol. 2025 Oct 20. doi: 10.1681/ASN.0000000902.
    PubMed        
    
    

    
    J Clin Endocrinol Metab

75. HE JH, Bennett WL, Ma J, Oyeka CP, et al
    Sex Hormones Mediate Intensive Lifestyle Intervention-Induced Bone Mineral Density Changes: Look AHEAD Sex Hormone Study.
    J Clin Endocrinol Metab. 2025 Jun 17:dgaf359. doi: 10.1210.
    PubMed         Abstract available
    
    
76. PRAHALAD P, Ding VY, Zaharieva DP, Addala A, et al
    Sustained HbA1c Improvements Over 36 Months in Youth in the Teamwork, Targets, Technology, and Tight Control (4T) Study.
    J Clin Endocrinol Metab. 2026;111:418-426.
    PubMed         Abstract available
    
    
77. CAO S, Cao S
    Hyperglycemic Hypernatremic Hypertonic State: A Predominant HHS Subtype and Its Clinical and Diagnostic Features.
    J Clin Endocrinol Metab. 2026;111:e406-e413.
    PubMed         Abstract available
    
    
78. VANLAER Y, Minschart C, Reyns F, Myngheer N, et al
    Treatment adherence and satisfaction of a mobile-based lifestyle intervention in women with prior gestational diabetes.
    J Clin Endocrinol Metab. 2026 Jan 21:dgag019. doi: 10.1210.
    PubMed         Abstract available
    
    
79. 
    Correction to: "Risk of Type 2 Diabetes, MASLD and Cardiovascular Disease in People Living With Polycystic Ovary Syndrome".
    J Clin Endocrinol Metab. 2026;111:e646.
    PubMed        
    
    

    
    J Nutr

80. MANSOUR A, Amrollahi Bioky A, Gerami H, Khorasanian AS, et al
    Efficacy of Oral Vitamin B12 at 1000 mcg versus 2000 mcg on Neuropathic Outcomes in Patients with Diabetic Peripheral Neuropathy and Low Serum Vitamin B12: A Randomized Clinical Trial.
    J Nutr. 2026 Jan 16:101368. doi: 10.1016/j.tjnut.2026.101368.
    PubMed         Abstract available
    
    
81. CAPRA BT, Hudson S, Phillips KM, Elaina ML, et al
    Chemical Analysis of Controlled Diets High in and Free of Ultra-processed Foods (UPF) and Proof-of-Concept Findings: Reducing UPF Consumption May Lower Diabetes Risk in Mid-life Adults.
    J Nutr. 2026 Jan 21:101370. doi: 10.1016/j.tjnut.2026.101370.
    PubMed         Abstract available
    
    

    
    JAMA

82. NEUEN BL, Fletcher RA, Anker SD, Bhatt DL, et al
    SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta-Analysis.
    JAMA. 2026;335:233-244.
    PubMed         Abstract available
    
    
83. MAUERMANN ML, Staff NP
    Peripheral Neuropathy: A Review.
    JAMA. 2025 Nov 17. doi: 10.1001/jama.2025.19400.
    PubMed         Abstract available
    
    
84. ANDERER S
    Higher Food Preservative Intake Linked With Type 2 Diabetes.
    JAMA. 2026 Jan 23. doi: 10.1001/jama.2025.23033.
    PubMed        
    
    

    
    Ophthalmology

85. SHAH J, Razavi P, Festok M, Ahmed H, et al
    Tirzepatide and Reduced Risk of Diabetic Retinopathy and Related Complications: A Multicenter U.S. Cohort Study.
    Ophthalmology. 2026 Jan 21:S0161-6420(26)00019.
    PubMed         Abstract available
    
    

    
    Pediatr Diabetes

86. VURALLI D
    From Pathophysiology to Treatment: Contemporary Approaches to CFRD in the Pediatric and Adolescent Population.
    Pediatr Diabetes. 2026;2026:5539725.
    PubMed         Abstract available
    
    
87. YEN HC, Lin CH, Lin MC
    Maternal Autoimmune Disease and Childhood-Onset Type 1 Diabetes: A Nationwide Population-Based Nested Case-Control Study.
    Pediatr Diabetes. 2026;2026:3418021.
    PubMed         Abstract available
    
    

    
    PLoS One

88. AL-HUSSEIN F, Tafakori L, Abdollahian M, Al-Shali K, et al
    Developing count regression techniques for predicting the number of new type 2 diabetes cases in Saudi Arabia.
    PLoS One. 2026;21:e0341436.
    PubMed         Abstract available
    
    
89. KUWABARA Y, Morishima T, Kudo H, Shimadzu Kato M, et al
    Impact of coexisting diabetes on the development of cardiovascular disease and death in patients with cancer.
    PLoS One. 2026;21:e0337946.
    PubMed         Abstract available
    
    
90. SURYA J, Tamilselvi S, Roy M, Chinnasamy S, et al
    Machine learning-based prediction of diabetic retinopathy from pupillary abnormalities in a South Indian population.
    PLoS One. 2026;21:e0340802.
    PubMed         Abstract available
    
    
91. YANG D, Zhang Y, Ji L, Wu J, et al
    The shared biomarkers and molecular mechanisms of systemic lupus erythematosus and type 2 diabetes.
    PLoS One. 2026;21:e0340312.
    PubMed         Abstract available
    
    
92. GALLARDO-ALBURQUEQUE LA, Quispe-Landeo Y, Chaname-Marin A, Uribe-Cavero LJ, et al
    External validation of the Meggitt-Wagner, Texas University, SINBAD, and Saint Elian classifications for predicting major amputation in patients with diabetes at a public hospital in Peru.
    PLoS One. 2026;21:e0327601.
    PubMed         Abstract available
    
    
93. LECKY R, Grogan S, Shukla P, Atkinson S, et al
    The role of obesity and Type 2 diabetes in lung health: A systematic review (2024).
    PLoS One. 2026;21:e0340692.
    PubMed         Abstract available
    
    

    
    Transplantation

94. AMOR AJ, Ferrer-Fabrega J
    Improving Bone Health in Type 1 Diabetes and Chronic Kidney Disease: The Overlooked Benefit of Simultaneous Pancreas-Kidney Transplantation.
    Transplantation. 2026 Jan 23. doi: 10.1097/TP.0000000000005631.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum